Evidence map›Paper›PMID 36161874›Full record

ArticleHuman vaccines & immunotherapeutics2022

Willingness to accept human papillomavirus vaccination in Jimma town, Ethiopia.

Tsegaw Biyazin, Aynalem Yetwale, Belete Fenta

Open access · goldAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tsegaw BiyazinInstitute of Health, Faculty of Health Science, School of midwifery, Jimma University, Jimma, Ethiopia.ORCID 0000-0002-2906-2382
Aynalem YetwaleInstitute of Health, Faculty of Health Science, School of midwifery, Jimma University, Jimma, Ethiopia.
Belete FentaInstitute of Health, Faculty of Health Science, School of midwifery, Jimma University, Jimma, Ethiopia.
Jimma University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination against HPV is effective against cervical cancer, and the success of HPV vaccination is determined by the willingness to accept the vaccine. Therefore, the purpose of this study was to assess willingness to be vaccinated among female high school students, in Jimma town, Ethiopia. A cross-sectional study was conducted with female high school students in Jimma town, Ethiopia. Study participants were selected using a simple random sampling method. Data were collected using a self-administered method. Data were entered using Epi-data version 3.5, exported, and analyzed using the statistical package for the social sciences (SPSS) version 21. Pearson's chi-square test was used for data analysis. Finally, the results were narrated using text, tables, and graphs. A total, of 366 study participants were interviewed and yielded a response rate of 94.8%. The majority of responders (267 or 72.9%) belonged to the age class 16-20 years. Two-thirds 68.9% of respondents were willing to take HPV vaccines. Respondents' mother education (P = .041), respondents who had an older sister (P = .014), who had a smartphone (P = .043), knowledge (P = .001), and attitude (P = .006) variables were significantly associated with willingness to accept HPV vaccine. Only two-thirds of the study participants were willing to vaccinate. Responders' mother education status, responders who had an older sister, smartphone, good knowledge, and a favorable attitude toward HPV vaccine were significantly associated with HPV vaccine acceptance. All concerned bodies have to enhance the willingness of the target population to take HPV vaccination.

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsAdolescentAdultCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHuman Papillomavirus VirusesHumansPatient Acceptance of Health CareSurveys and QuestionnairesVaccinationYoung AdultPapillomavirus VaccinesHuman papilloma virusvaccinewillingness

Identifiers

PMID36161874
PMCPMC9746436
OpenAlexW4297259934

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.